Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-09-30
1997-10-21
Jordan, Kimberly
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514114, 5142355, 514255, 514278, 514302, 514318, 514337, 514392, 514821, A61K 3166, A61K 31535, A61K 31495, A61K 3144, A61K 31445, A61K 31415, A61K 3135
Patent
active
056797060
ABSTRACT:
A method for the concomitant treatment of ischemia and arrhythmia in mammalian species which includes administering a combination of a potassium channel opener having little or no effect on action potential duration in the heart and a class III antiarrhythmic compound.
REFERENCES:
patent: 4721809 (1988-01-01), Buzby et al.
patent: 4876262 (1989-10-01), Oinuma et al.
patent: 4959366 (1990-09-01), Cross et al.
patent: 4996215 (1991-02-01), Oinuma et al.
patent: 5034411 (1991-07-01), Almgren et al.
patent: 5089526 (1992-02-01), Simon et al.
patent: 5140031 (1992-08-01), Atwal et al.
patent: 5276168 (1994-01-01), Atwal
patent: 5374643 (1994-12-01), Atwal et al.
Yao et al., "Effects of the K.sub.ATP Channel Opener Bimakalim on Coronary Blood Flow, Monophasic Action Potential Duration, and Infarct Size in Dogs", Cir., vol. 89, No. 4, 1994, pp. 1769-1775.
D'Alonzo Albert J.
Grover Gary J.
Bristol--Myers Squibb Company
Jordan Kimberly
Park Ellen K.
LandOfFree
Combination of a potassium channel activator and an antiarrhythm does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Combination of a potassium channel activator and an antiarrhythm, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combination of a potassium channel activator and an antiarrhythm will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1007156